Svoronos Dawn
Insider CIK 1574579 · MDVN Director · PTCT Director · ECYT Director · ADVM Director · XENE Director · GBT Director · SLRN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-09-01 | 2026-09-03 | 5,144 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-09-01 | 2026-09-03 | 5,144 | $8.15 | $41.9K | 31,373 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-09-01 | 2026-09-03 | 5,144 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-09-01 | 2026-09-03 | 5,144 | $8.15 | $41.9K | 31,373 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2026-06-03 | 2026-06-03 | 1,593 | — | $0 | 1,593 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2026-06-03 | 2026-06-03 | 10,507 | — | $0 | 10,507 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-06-01 | 2026-06-03 | 2,645 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | F Tax w/h | 2026-06-01 | 2026-06-03 | 1,416 | $53.41 | $75.6K | 26,229 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-06-01 | 2026-06-03 | 2,645 | — | $0 | 27,645 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,450 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,520 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,500 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | U Tender | 2025-12-09 | 2025-12-10 | 5,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 17,012 | — | $0 | 17,012 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 2,645 | — | $0 | 2,645 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 23,243 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 92,158 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 155,450 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer | 2025-05-21 | 2025-05-23 | 15,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2024-06-17 | 2024-06-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award deriv | 2024-06-07 | 2024-06-11 | 92,158 | — | $0 | 92,158 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2024-06-05 | 2024-06-05 | 15,542 | — | $0 | 15,542 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2023-08-24 | 2023-08-24 | 25,000 | $38.70 | $967.5K | 25,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2023-06-09 | 2023-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2023-06-02 | 2023-06-02 | 18,475 | — | $0 | 18,475 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 155,450 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 155,450 | — | $0 | 155,450 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 23,243 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 23,243 | — | $0 | 23,243 | SEC↗ |
| SLRN ACELYRIN, Inc. | P Buy | 2023-05-09 | 2023-05-11 | 15,000 | $18.00 | $270.0K | 15,000 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award deriv | 2023-05-04 | 2023-05-04 | 23,243 | — | $0 | 23,243 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 5,600 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 5,600 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 5,247 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 7,500 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 30,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 3,600 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2022-10-05 | 2022-10-06 | 5,376 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2022-06-28 | 2022-06-29 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2022-06-21 | 2022-06-22 | 1,908 | $27.24 | $52.0K | 5,376 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-06-14 | 2022-06-16 | 3,600 | — | $0 | 3,600 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-06-14 | 2022-06-16 | 5,600 | — | $0 | 5,600 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-06-14 | 2022-06-16 | 3,600 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-06-14 | 2022-06-16 | 3,600 | — | $0 | 7,284 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2022-06-10 | 2022-06-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2022-06-09 | 2022-06-10 | 738 | $27.20 | $20.1K | 29,017 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2022-05-16 | 2022-05-18 | 30,000 | $0.85 | $25.5K | 50,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2022-01-07 | 2022-01-11 | 12,000 | — | $0 | 12,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2022-01-07 | 2022-01-11 | 510 | $38.53 | $19.7K | 26,555 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2022-01-07 | 2022-01-11 | 3,200 | — | $0 | 29,755 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2021-06-18 | 2021-06-21 | 1,609 | $36.54 | $58.8K | 3,684 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-06-17 | 2021-06-21 | 3,600 | — | $0 | 3,600 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-06-17 | 2021-06-21 | 5,600 | — | $0 | 5,600 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-06-17 | 2021-06-21 | 3,037 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-06-17 | 2021-06-21 | 3,037 | — | $0 | 5,293 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2021-06-09 | 2021-06-11 | 365 | $41.89 | $15.3K | 27,065 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2021-06-03 | 2021-06-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2021-05-12 | 2021-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2021-03-31 | 2021-04-01 | 20,000 | $10.02 | $200.4K | 20,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2021-02-01 | 2021-02-02 | 506 | $56.96 | $28.8K | 27,430 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2021-01-06 | 2021-01-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2021-01-06 | 2021-01-08 | 1,650 | — | $0 | 27,936 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2020-12-09 | 2020-12-11 | 45,000 | — | $0 | 45,000 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-06-19 | 2020-06-19 | 1,663 | $63.69 | $105.9K | 3,137 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-06-19 | 2020-06-19 | 881 | $64.42 | $56.8K | 2,256 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-06-17 | 2020-06-19 | 3,037 | — | $0 | 3,037 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-06-17 | 2020-06-19 | 4,800 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-06-17 | 2020-06-19 | 5,247 | — | $0 | 5,247 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-06-17 | 2020-06-19 | 4,800 | — | $0 | 4,800 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | S Sale | 2020-06-11 | 2020-06-12 | 364 | $48.36 | $17.6K | 26,286 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2020-06-01 | 2020-06-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2020-01-29 | 2020-01-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award | 2020-01-29 | 2020-01-31 | 1,650 | — | $0 | 26,650 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2019-09-16 | 2019-09-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-06-18 | 2019-06-20 | 4,800 | — | $0 | 4,800 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-06-18 | 2019-06-20 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2019-01-22 | 2019-01-24 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $13.19 | $257.2K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 22,500 | $13.19 | $296.8K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 3,750 | $24.00 | $90.0K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 3,300 | $24.00 | $79.2K | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-12-19 | 2018-12-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2018-06-04 | 2018-06-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ECYT ENDOCYTE INC | A Award deriv | 2018-05-03 | 2018-05-04 | 42,000 | — | $0 | 42,000 | SEC↗ |
| ECYT ENDOCYTE INC | A Award | 2018-05-03 | 2018-05-04 | 7,050 | — | $0 | 7,050 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2018-01-03 | 2018-01-05 | 14,000 | — | $0 | 14,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2017-08-14 | 2017-08-15 | 50,000 | $2.82 | $141.0K | 50,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2017-06-01 | 2017-06-02 | 3,500 | — | $0 | 3,500 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | P Buy | 2017-05-23 | 2017-05-24 | 25,000 | $13.49 | $337.3K | 25,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2017-01-03 | 2017-01-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 12,232 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 30,000 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 9,584 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,228 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,284 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 11,046 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | U Tender | 2016-09-28 | 2016-09-30 | 21,206 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2016-09-27 | 2016-09-27 | 5,144 | — | $0 | 5,144 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2016-06-22 | 2016-06-23 | 6,228 | — | $0 | 6,228 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2016-06-22 | 2016-06-23 | 2,972 | — | $0 | 21,206 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | A Award deriv | 2016-06-10 | 2016-06-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2016-03-14 | 2016-03-16 | 6,000 | $38.90 | $233.4K | 18,234 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-09-08 | 2015-09-08 | 3,100 | $89.15 | $276.4K | 12,117 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2015-06-16 | 2015-06-18 | 3,142 | — | $0 | 3,142 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2015-06-16 | 2015-06-18 | 1,578 | — | $0 | 15,217 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-03-02 | 2015-03-04 | 3,350 | $119.75 | $401.2K | 13,639 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2014-10-15 | 2014-10-16 | 5,523 | — | $0 | 5,523 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2014-10-15 | 2014-10-16 | 3,682 | — | $0 | 16,989 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2014-06-27 | 2014-07-01 | 4,792 | — | $0 | 4,792 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2014-06-27 | 2014-07-01 | 2,250 | — | $0 | 13,307 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2013-06-28 | 2013-07-02 | 6,116 | — | $0 | 6,116 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2013-06-28 | 2013-07-02 | 3,557 | — | $0 | 11,057 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2013-04-30 | 2013-04-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2013-04-22 | 2013-04-23 | 7,500 | — | $0 | 7,500 | SEC↗ |